The Quality of Life of Diabetes Mellitus Patients Treated with Oral Antidiabetic Therapy of Prolanis Program at Puskesmas Ujung Berung Indah Bandung 2017
The quality of life of Diabetes Mellitus (DM) patients will affect some aspects of their lives, so that Indonesian Government through Badan Penyelenggaraan Jaminan Sosial (BPJS) Kesehatan holds a program known as Program Pengelolaan Penyakit Kronis (Prolanis). Prolanis is an integrated program which involves its participants, health facilities and BPJS Kesehatan to reach the optimum quality of life at effective and efficient health cost. This study aimed to define the quality of life (QoL) of Prolanis Participants who were treated with Oral Antidiabetic drugs (OAD) Therapy at Puskesmas Ujung Berung Indah Bandung, based on patients‘ characteristics and the pattern of OAD given to the patients. This research used Cross Sectional design. The data was collected concurrently from interviews and participants‘ medical records. The subjects were DM type 2 patients who has been participating in Prolanis for at least 4 months and treated with OAD Therapy. The QoL was measured by Diabetes quality of life clinical trial questionnaire (DQLCTQ). The data was analized by using independent sample t-test. The result showed that the average QoL score of patients with OAD therapy was 69,1 whilst those with combined OAD therapy had the average score of 76,2. Thus, the pattern of the therapy was considered to affect the life QoL (p=0,021) meanwhile gender, age education background, regular income, DM duration and complication did not affect the quality of life.